Covid-19

  • Update in cutaneous manifestations of COVID-19: Special populations
    Update in cutaneous manifestations of COVID-19: Special populations
    Samantha Polly, MD, Inga M. Muser, MD and Anthony P. Fernandez, MD, PhD
    Cleveland Clinic Journal of Medicine January 2023, 90 (1) 43-52; DOI: https://doi.org/10.3949/ccjm.90a.22013

    Recognition of skin reactions and their implications is beneficial to clinicians in shaping patient counseling and anticipatory guidance. An illustrated guide.

  • Common skin signs of COVID-19 in adults: An update
    Samantha Polly, MD and Anthony P. Fernandez, MD, PhD
    Cleveland Clinic Journal of Medicine March 2022, 89 (3) 161-167; DOI: https://doi.org/10.3949/ccjm.89a.21126

    Cutaneous findings can be clues to the diagnosis and infection severity in viral illnesses, including COVID-19.

  • Update to COVID-19 serologic testing : FAQs and caveats
    Kamran Kadkhoda, PhD, D(ABMM), D(ABMLI)
    Cleveland Clinic Journal of Medicine January 2022, DOI: https://doi.org/10.3949/ccjm.87a.20054-up
  • A perspective on discussing COVID-19 vaccines: Efficacy and adverse effects
    Brian F. Mandell, MD
    Cleveland Clinic Journal of Medicine December 2021, 88 (12) 644-645; DOI: https://doi.org/10.3949/ccjm.88b.12021

    Physicians should be vigilant and open-minded regarding possible adverse reactions to the vaccines, and should take time to discuss the demonstrated efficacy of vaccines with patients.

  • COVID-19 vaccine-induced cellulitis and myositis
    Sathishkumar Ramalingam, MD, Harkesh Arora, MD, Susan Lewis, MD, Kulothungan Gunasekaran, MD, Maheswari Muruganandam, MD, Sivakumar Nagaraju, MD and Priyesh Padmanabhan, MD
    Cleveland Clinic Journal of Medicine December 2021, 88 (12) 648-650; DOI: https://doi.org/10.3949/ccjm.88a.21038

    The day after receiving the second dose of the mRNA vaccine, redness and pain developed at the injection site, eventually involving the whole left arm and shoulder.

  • Neuropsychiatric assessment and management of the ICU survivor
    Erin A. Dean, MD, Michelle Biehl, MD, Kathryn Bash, APRN, CNP, Jeremy Weleff, DO and Leopoldo Pozuelo, MD
    Cleveland Clinic Journal of Medicine December 2021, 88 (12) 669-679; DOI: https://doi.org/10.3949/ccjm.88a.20169

    Post-intensive care syndrome occurs in 50% to 70% of ICU survivors. The authors examine various facets of this syndrome and emphasize the role of post-ICU recovery clinics.

  • Another influenza season in the shadow of the COVID-19 pandemic
    Another influenza season in the shadow of the COVID-19 pandemic
    Sherif Beniameen Mossad, MD, FACP, FIDSA, FAST
    Cleveland Clinic Journal of Medicine November 2021, 88 (11) 594-597; DOI: https://doi.org/10.3949/ccjm.88a.21095

    Flu season is upon us at the ominous milestone of more than 722,000 US deaths from COVID-19.

  • Update to post-acute sequelae of SARS-CoV-2 infection: Caring for the 'long-haulers'
    Susan Vehar, MD, Marina Boushra, MD, Prince Ntiamoah, MD and Michelle Biehl, MD, MS
    Cleveland Clinic Journal of Medicine October 2021, DOI: https://doi.org/10.3949/ccjm.88a.21010-up
  • The initial viral infection may be only part of the story
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine September 2021, 88 (9) 476-477; DOI: https://doi.org/10.3949/ccjm.88b.09021

    We clearly see that the coronavirus elicits syndromes far afield from respiratory tissues. But a virus eliciting effects seemingly distinct from the primary infection is nothing new.

  • Dermatomyositis-related interstitial lung disease mimicking COVID-19 pneumonia
    Satoshi Hayano, MD, Kenichiro Tokunaga, MD, Yusuke Imamura, MD and Hideto Oshikawa, MD
    Cleveland Clinic Journal of Medicine September 2021, 88 (9) 484-486; DOI: https://doi.org/10.3949/ccjm.88a.20204

    A subtype of myositis with characteristic skin rashes and ulcers, amyopathic or hypomyopathic symptoms, and rapidly progressive ILD.

Pages